BTX has been at the forefront of electroporation technology since we introduced the first commercially available electroporator in 1983. For over 30 years, we have made it our priority to focus only on electroporation and electrofusion. This focus has allowed us to develop the experience and expertise to supply you with a broad selection of innovative in vivo and in vitro tools to advance your research.
Whatever your need, our range of electroporation systems and accessories covers virtually every electroporation and electrofusion application, including high throughput applications. Additionally BTX provides exceptional applications support and service before, during and after your purchase to ensure your success.
Our comprehensive library of protocols and publications, along with the expertise of our technical staff, will make addressing your application needs easier. Thousands of users have published papers on many species, including mammals, bacteria, fruit flies, nematodes, chickens, frogs, muscles, liver, brains, embryos, and muscles, in vivo and in vitro. Put the BTX advantage to work for you!
BTX is part of the Harvard Bioscience family of companies. Harvard Bioscience (Nasdaq: HBIO) is a global developer, manufacturer and marketer of a broad range of specialized products, primarily scientific instruments.